BACKGROUND: Because of established links between entrenched poverty and risk of HIV infection, there have long been warnings that HIV/AIDS will disproportionately affect Aboriginal people in Canada. We compared HIV incidence rates among Aboriginal and non-Aboriginal injection drug users (IDUs) in Vancouver and studied factors associated with HIV seroconversion among Aboriginal participants. METHODS: This analysis was based on 941 participants (230 Aboriginal people) recruited between May 1996 and December 2000 who were seronegative at enrollment and had completed at least one follow-up visit. Incidence rates were calculated using the Kaplan-Meier method. The Cox proportional hazards regression model was used to identify independent predictors of time to HIV seroconversion among female and male Aboriginal IDUs. RESULTS: As of May 31, 2001, seroconversion had occurred in 112 (11.9%) of the participants, yielding a cumulative incidence of HIV infection at 42 months of 12.7% (95% confidence interval [CI] 10.3%-15.1%). The cumulative incidence at 42 months was significantly higher among the Aboriginal participants than among the non-Aboriginal participants (21.1% v. 10.7%, p < 0.001). This elevation in risk was present in both female and male Aboriginal IDUs. Among the female Aboriginal IDUs, frequent speedball (combined cocaine and heroin) injection (adjusted relative risk [RR] 3.1; 95% CI 1.4-7.1) and going on binges of injection drug use (adjusted RR 2.3; 95% CI 1.0-5.2) were found to be independent predictors of HIV seroconversion. Among the male Aboriginal IDUs, the independent predictors of seroconversion were frequent speedball injection (adjusted RR 2.9; 95% CI 1.0-8.5) and frequent cocaine injection (adjusted RR 2.5; 95% CI 1.0-6.5). INTERPRETATION: In Vancouver, Aboriginal IDUs are becoming HIV positive at twice the rate of non-Aboriginal IDUs. Our findings emphasize the urgent need for an appropriate and effective public health strategy--planned and implemented in partnership with Aboriginal AIDS service organizations and the Aboriginal community--to reduce the harms of injection drug use in this population.
BACKGROUND: Because of established links between entrenched poverty and risk of HIV infection, there have long been warnings that HIV/AIDS will disproportionately affect Aboriginal people in Canada. We compared HIV incidence rates among Aboriginal and non-Aboriginal injection drug users (IDUs) in Vancouver and studied factors associated with HIV seroconversion among Aboriginal participants. METHODS: This analysis was based on 941 participants (230 Aboriginal people) recruited between May 1996 and December 2000 who were seronegative at enrollment and had completed at least one follow-up visit. Incidence rates were calculated using the Kaplan-Meier method. The Cox proportional hazards regression model was used to identify independent predictors of time to HIV seroconversion among female and male Aboriginal IDUs. RESULTS: As of May 31, 2001, seroconversion had occurred in 112 (11.9%) of the participants, yielding a cumulative incidence of HIV infection at 42 months of 12.7% (95% confidence interval [CI] 10.3%-15.1%). The cumulative incidence at 42 months was significantly higher among the Aboriginal participants than among the non-Aboriginal participants (21.1% v. 10.7%, p < 0.001). This elevation in risk was present in both female and male Aboriginal IDUs. Among the female Aboriginal IDUs, frequent speedball (combined cocaine and heroin) injection (adjusted relative risk [RR] 3.1; 95% CI 1.4-7.1) and going on binges of injection drug use (adjusted RR 2.3; 95% CI 1.0-5.2) were found to be independent predictors of HIV seroconversion. Among the male Aboriginal IDUs, the independent predictors of seroconversion were frequent speedball injection (adjusted RR 2.9; 95% CI 1.0-8.5) and frequent cocaine injection (adjusted RR 2.5; 95% CI 1.0-6.5). INTERPRETATION: In Vancouver, Aboriginal IDUs are becoming HIV positive at twice the rate of non-Aboriginal IDUs. Our findings emphasize the urgent need for an appropriate and effective public health strategy--planned and implemented in partnership with Aboriginal AIDS service organizations and the Aboriginal community--to reduce the harms of injection drug use in this population.
Authors: E Wood; M W Tyndall; P M Spittal; K Li; T Kerr; R S Hogg; J S Montaner; M V O'Shaughnessy; M T Schechter Journal: CMAJ Date: 2001-08-21 Impact factor: 8.262
Authors: Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter Journal: AIDS Date: 2002-04-12 Impact factor: 4.177
Authors: Gail E Wyatt; Hector F Myers; John K Williams; Christina Ramirez Kitchen; Tamra Loeb; Jennifer Vargas Carmona; Lacey E Wyatt; Dorothy Chin; Nicole Presley Journal: Am J Public Health Date: 2002-04 Impact factor: 9.308
Authors: Patricia M Spittal; Kevin J P Craib; Evan Wood; Nancy Laliberté; Kathy Li; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter Journal: CMAJ Date: 2002-04-02 Impact factor: 8.262
Authors: M W Tyndall; K J Craib; S Currie; K Li; M V O'Shaughnessy; M T Schechter Journal: J Acquir Immune Defic Syndr Date: 2001-12-01 Impact factor: 3.731
Authors: Evan Wood; Patricia M Spittal; Will Small; Thomas Kerr; Kathy Li; Robert S Hogg; Mark W Tyndall; Julio S G Montaner; Martin T Schechter Journal: CMAJ Date: 2004-05-11 Impact factor: 8.262
Authors: Michael V O'Shaughnessy; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner Journal: Curr HIV/AIDS Rep Date: 2012-12 Impact factor: 5.071
Authors: Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg Journal: CMAJ Date: 2003-09-30 Impact factor: 8.262
Authors: Margo E Pearce; Wayne M Christian; Katharina Patterson; Kat Norris; Akm Moniruzzaman; Kevin J P Craib; Martin T Schechter; Patricia M Spittal Journal: Soc Sci Med Date: 2008-06 Impact factor: 4.634